Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
26.08B
Market cap26.08B
Price-Earnings ratio
25.10
Price-Earnings ratio25.10
Dividend yield
1.40%
Dividend yield1.40%
Average volume
1.26M
Average volume1.26M
High today
$238.25
High today$238.25
Low today
$235.69
Low today$235.69
Open price
$236.98
Open price$236.98
Volume
732.94K
Volume732.94K
52 Week high
$248.84
52 Week high$248.84
52 Week low
$171.18
52 Week low$171.18

Stock Snapshot

Quest Diagnostics(DGX) stock is priced at $236.32, giving the company a market capitalization of 26.08B. It carries a P/E multiple of 25.10 and pays a dividend yield of 1.40%.

On 2026-09-26, Quest Diagnostics(DGX) stock traded between a low of $235.69 and a high of $238.25. Shares are currently priced at $236.32, which is +0.3% above the low and -0.8% below the high.

The Quest Diagnostics(DGX)'s current trading volume is 732.94K, compared to an average daily volume of 1.26M.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $248.84 and a 52-week low of $171.18.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $248.84 and a 52-week low of $171.18.

DGX News

Nasdaq 23h
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?

Quest Diagnostics’ DGX shares have rallied 36.3% so far this year, highlighting strong momentum. The stock has outperformed the industry, which has gained 20%,...

Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
Simply Wall St 2d
Quest Diagnostics Apple Health Push Leaves Valuation Question Open

Quest Diagnostics (DGX) is back in focus after announcing an Apple Health integration that lets iPhone and iPad users order a US$119 preventive lab panel checki...

Quest Diagnostics Apple Health Push Leaves Valuation Question Open
Nasdaq 4d
Why Quest Diagnostics Holdings Stock Dropped Today

Key Points Medicare and Medicaid have been overpaying Quest Diagnostics for years, says the government. Starting next year, they plan to cut reimbursement of...

Why Quest Diagnostics Holdings Stock Dropped Today

Analyst ratings

50%

of 20 ratings
Buy
45%
Hold
50%
Sell
5%

More DGX News

TipRanks 4d
CMS 2027 CLFS proposal skews towards ‘worst end’ for Quest, says Jefferies

After CMS released the preliminary 2027 clinical laboratory fee schedule, concluding that it has overpaid versus commercial market rates by 16% and proposing cu...

Nasdaq 4d
Is This the Right Time to Add DGX Stock to Your Portfolio?

Quest Diagnostics DGX is gaining momentum across physician, hospital and consumer channels, supported by customer wins, acquisitions and expanded offerings. The...

Is This the Right Time to Add DGX Stock to Your Portfolio?
TipRanks 5d
Quest Diagnostics price target raised to $260 from $250 at Truist

Truist raised the firm’s price target on Quest Diagnostics (DGX) to $260 from $250 and keeps a Hold rating on the shares as part of a broader research note upda...

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.